OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |
| SECTORAL ASSET MANAGEMENT INC | 437,652 | $5,405,002 | 1.05% |
| Aquilo Capital Management, LLC | 88,875 | $1,097,606 | 1.00% |
| Deep Track Capital, LP | 1,930,894 | $23,846,541 | 0.92% |
| Endurant Capital Management LP | 58,573 | $723,377 | 0.65% |
| EAM Investors, LLC | 243,290 | $3,004,632 | 0.58% |
| Kynam Capital Management, LP | 235,176 | $2,904,424 | 0.48% |
| Newtyn Management, LLC | 150,000 | $1,852,500 | 0.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 210,000 | $2,593,500 | 0.30% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 98,600 | $1,217,710 | 0.14% |
| Woodline Partners LP | 717,332 | $8,859,050 | 0.10% |
External links
This page lists OLEMA PHARMACEUTICALS INC's shareholders in Q3 2023. To view OLEMA PHARMACEUTICALS INC's shareholder history, click here.